Formulated for glaucoma to manage intraocular pressure and support vision maintenance.
Mechanism of Action
Dorzolamide reduces the secretion of aqueous humor by inhibiting carbonic anhydrase. Timolol blocks beta receptors to further decrease humor production. This dual action provides effective and sustained reduction of pressure within the eye.
Route of Administration
Ophthalmic
Onset Time
2 hours
Duration
12 hours
Contraindications
Bronchial asthma, Severe COPD, Sinus bradycardia, Second or third degree heart block, Cardiogenic shock
Severe Adverse Events
Bronchospasm, Severe bradycardia, Stevens-johnson syndrome — requires immediate medical attention
Information related to Cosopt is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
